Please note, endo sessions has been updated to remove some site content from past Endocrine Society programs.
If you have any questions please contact [email protected].
Search:
Search for text in:
separate each search
term with a space
term with a space
Multiple terms:
Quick Links:
Additional Search Filters:
Access:
Availability:
Showing session: reset
What's New in 131-I Refractory Thyroid Cancer?
| Browse by: | Sort by: |
Targeting the Sodium Iodide Symporter to Increase RAI Uptake
Christopher McCabe, PhD
University of Birmingham, Birmingham, United Kingdom
Available
Developing Novel Combination Therapies for Medullary Thyroid Cancer
Rozita Bagheri-Yarmand, PhD
University of Texas MD Anderson Cancer Center, Houston, TX
Available
Genetic Determinants Underlying Radioiodine Refractory Thyroid Cancer
Sissy Jhiang, PhD
The Ohio State University Medical Center, Columbus, OH
Available
Abstract Presentation: Aggressive Thyroid Cancer is Associated With Suppressor Circulating Immunophenotype
Anupam Kotwal, MD
Univ. of Nebraska Medical Center, Omaha, NE
Available
